Arkolith/Insider Trading/TEVA/Form 4

Shields Matthew

EVP, Global OperationsTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) · full profile →Form 4 · filed Mar 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$548K
Net Open-Market Flow
-$548K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Sell(S)17K$31.67$548K10K
Mar 5, 2026Option exercise(M)17K——27K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 5, 2026Option exercise(M)17K—$052K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-098473) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML